new glp 1 agonist GLP-1 Agonists in Cardiovascular Diseases: Mechanisms, Clinical Evidence, and Emerging Therapies Beyond GLP-1: New 5-In-1 Compound

Retatrutide, Amycretin, Survodutide, VK2735, and MariTide are among the most watched pipeline assets heading into 2026 because each represents a different answer to the same commercial question: what comes after Ozempic, Wegovy, Mounjaro, and Zepbound

J Huazhong Univ Sci Technolog Med Sci 25:127130 Tan Y, Tang Q, Hu BR, Xiang J (2007) Antioxidant properties of berberine on cultured rabbit corpus cavernosum smooth muscle cells injured by hydrogen peroxide

Some providers request blood work or other assessments before starting a new cycle

Spot-fading serums are ineffective without proper protection, as UV radiation can immediately darken spots again